ArticlemedRxiv : the preprint server for health sciences2025
HLA-DQB1*03:01 strongly affects age of onset of type 1 narcolepsy independently of DQA1 and ethnicity.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
29 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we investigated the effects of HLA-DQB1*03:01 on the onset age of type-1 narcolepsy. We pooled data from 5,339 cases from China, Europe, Korea, Japan, and the United States to conduct the first transethnic study on age of onset (OA). GWAS was used to detect the associated genes. HLA alleles were imputed by HIBAG. Three datasets (DGN, CHINA, and CAUC) were used for TCR analyses. Chinese patients were found to have an earlier age of onset. Independently of this, only one strong GWAS significant effect was observed, summarized by the presence of DQB1*03:01 and centered around the coding region of this gene. In contrast, DQ0602 dosage did not strongly affect onset, and other known narcolepsy-associated genetic loci had minor effects. The DQB1*03:01 effect (mean -3.47 years, p=1.7 10-18) showed no heterogeneity across ethnic groups and was independent of common allelic variation at DQA1 in cis of DQB1*03:01 (DQA1*03:03; DQA1*0505; DQA1*06:01). This effect may be explained by presentation of peptide(s) across all DQ0301 heterodimers, or, considering genetic effects mapping on TCRA and TCRB, effects on TCR repertoire. Using bulk and single-cell RNA-seq data across two ethnic groups, we found that DQB1*03:01 alters TCR repertoire at specific positions, most significantly within the CDR2A, CDR2B and CDR3B loops. These results illustrate the remarkable conservation of narcolepsy genetic effects across ethnicity and suggest that specific TCRs regulate narcolepsy onset. This result will likely be illuminating of the pathophysiology once T cells causative of the disease have been identified.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.